ASELAGE STEVE

Average Profitability
60.74%
Insider Buys Quantity
15
Insider Buys Sum
$547,984.40
Insider Sells Quantity
62
Insider Sells Sum
$20.49M

Insider Activity of ASELAGE STEVE

According to the SEC Form 4 filings, ASELAGE STEVE, being in a position of

  1. director at BioCryst Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 2500 shares for $16,000, and sold 0 shares,
    over all time since 2019-03-12, has bought 42500 shares for $114,120, and sold 0 shares.

The largest purchase of all time was on 2017-06-14 and amounted to 10000 shares of Travere Therapeutics, Inc. for $178,500.

The largest sale of all time was on 2012-07-02 and amounted to 95345 shares of BioMarin Pharmaceutical Inc. for $1.67M.

Biography of ASELAGE STEVE

No biography is available at this moment.

2024-05-24PurchaseBioCryst Pharmaceuticals, Inc.
BCRX
director
2,500
0.0012%
$6.40$16,000+22.68%
2022-05-11SaleTravere Therapeutics, Inc.
TVTX
2,575
0.0041%
$21.92$56,457+3.51%
2021-11-16SaleTravere Therapeutics, Inc.
TVTX
director
31,800
0.053%
$29.39$934,602-12.15%
2021-11-05SaleTravere Therapeutics, Inc.
TVTX
director
10,000
0.0146%
$26.23$262,300-13.52%
2021-11-02SaleTravere Therapeutics, Inc.
TVTX
director
3,500
0.0058%
$30.00$105,000-13.58%
2021-11-01SaleTravere Therapeutics, Inc.
TVTX
director
5,000
0.0083%
$29.48$147,400-11.89%
2021-10-07SaleTravere Therapeutics, Inc.
TVTX
director
60,000
0.1012%
$26.25$1.57M+1.35%
2021-05-11SaleTravere Therapeutics, Inc.
TVTX
director
2,146
0.0035%
$19.58$42,023+27.23%
2021-04-16SaleTravere Therapeutics, Inc.
TVTX
director
10,000
0.0174%
$26.23$262,300-0.04%
2021-03-17SaleTravere Therapeutics, Inc.
TVTX
director
17,727
0.031%
$27.44$486,456-10.92%
2021-02-02SaleTravere Therapeutics, Inc.
TVTX
director
25,000
0.0475%
$30.75$768,750-13.09%
2020-12-15SaleTravere Therapeutics, Inc.
TVTX
director
5,549
0.0117%
$26.02$144,385-4.22%
2020-12-02SaleTravere Therapeutics, Inc.
TVTX
director
7,891
0.0166%
$23.43$184,849+6.72%
2020-11-06SaleTravere Therapeutics, Inc.
TVTX
director
20,625
0.0463%
$23.00$474,375+13.58%
2020-11-05SaleTravere Therapeutics, Inc.
TVTX
director
2,500
0.0054%
$21.26$53,150+17%
2020-08-05SaleTravere Therapeutics, Inc.
TVTX
director
2,500
0.005%
$19.68$49,200+10.91%
2020-06-25SaleTravere Therapeutics, Inc.
TVTX
director
10,000
0.0224%
$20.00$200,000+7.81%
2020-05-14SaleTravere Therapeutics, Inc.
TVTX
director
3,062
0.0068%
$15.09$46,206+41.62%
2020-05-13SaleTravere Therapeutics, Inc.
TVTX
director
4,063
0.0096%
$16.41$66,674+38.34%
2020-05-12SaleTravere Therapeutics, Inc.
TVTX
director
1,000
0.0023%
$17.16$17,160+30.78%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.